If y’all haven’t noticed...
This board is holding all the shares.
And if the price goes lower..
The squeeze gets tighter.
Couple flippers took a loss.
Couple of em made a gain.
Throw a few thousand bucks around no big deal. Play with a few shares ok y’all have fun.
the position traders...
are looking for a bigger run.
A run that takes us to new support levels so that flippers can’t get in lower. An extinction event.
1.2 mil funding from NIH this year. Good. A lifeline. Yes. And thank Goodness for that. But here’s what the silver lining is..
Mymetics just signaled us again that they are planning on being around for a long time.
So what happens between now and the time the 5 year lifeline runs out?
For starters..
Anergis could drop a multi-million dollar upfront payment this month or next if the LCA is signed. And when phase 1 starts, a milestone payment, when phase two starts another milestone payment. Phase three and commercialization register more milestone payments and then royalties. Royalties on billions of dollars in projected peak sales by the year 2021 if commercialized. And perhaps “double digit” royalties...
That’s going to be multiple millions of dollars coming in in the very short term. More lifelines. But now there’s a surplus.
Ok so now Mr. Kempers might bring in Malaria funding. There’s two Malaria projects. With two different governments backing them. Swiss and NIH. If successful, more funding will come. What if the funding is large?
Maybe we get lucky and EtheRNA adopts our technology and strikes a new exclusive LCA for the adoption of virosomes in Cancer immunotherapy. Bump in share price for sure. More payments. Johnson and Johnson money.
“Mymetics is currently engaged with several small biotech companies in the oncology field to evaluate the improvements that can be generated in pre-clinical studies.
Mymetics is actively seeking additional partnerships to enhance existing cancer immunotherapies by use of the virosome VLP platform.”
More lifelines. But now they are not so much lifelines because the money is strong and is coming in from multiple angles. Now let’s just pursue our flu vaccine on our own, or with a new partner forget Sanofi, why not GSK, or Merck. LCA for flu vaccine? Why would they want that? Sanofi didn’t want it. Well why not have flu vaccine in non-cold strorage? Seems attractive to a Sanofi competitor.
Soon Toon Stegmann strikes a licensing deal for his new RSV vaccine. Another upfront payment for a pre-clinical vaccine.
Now the Swiss bank is loaded.
Chik vaccine kicks off, a few months later it’s ready for a new LCA. Don’t underestimate this one as we underestimated allergy. We don’t know the details yet.
The more money Mymetics brings in the more confident holders become in their investment.
I see funding coming from multiple angles and coming in succession year over year.
The flipper extinction event could come soon. It’s all about “Show us the money”
What you flippers gonna do if Bill Gates and the NIH drops 80 million on the Malaria vaccine.
What y’all gonna do when Johnson and Johnson signs a 50 million LCA on cancer virosomes ?
Then we trading for dollars aren’t we?
And you can’t get in.
AI
